Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement

Canadian Journal of Cardiology

Volumn 28, Issue 5, 2012, Pages 520-528

  Webb, John ^a   Rodés Cabau, Josep ^b   Fremes, Stephen ^c   Pibarot, Philippe ^b   Ruel, Marc ^d   Ibrahim, Reda ^e   Welsh, Robert ^f   Feindel, Christopher ^g   Lichtenstein, Samuel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THIENOPYRIDINE DERIVATIVE;

ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE; AORTA VALVE PROSTHESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; BIOPROSTHESIS; CANADA; CARDIOLOGIST; CLINICAL EFFECTIVENESS; CONSENSUS; ELECTROCARDIOGRAPHY MONITORING; FUNCTIONAL STATUS; HEALTH CARE COST; HEART FUNCTION; HEART LEFT VENTRICLE; HIGH RISK PATIENT; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORBIDITY; PATIENT SAFETY; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; REGISTER; RISK ASSESSMENT; STAFF TRAINING; SURGEON; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL; THROMBOEMBOLISM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; VASCULAR ACCESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CANADA; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84866367272     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.04.015     Document Type: Article

References (35)

1. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:e84-e231. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, et al, [errata in 2007;115:e409 and 2010;121:e443].
2. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
3. Clavel M.A., Webb J.G., Rodes-Cabau J., et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 2010, 122:1928-1936.
4. Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011, 364:2187-2198.
5. Makkar R.R., Fontana G.P., Jilaihawi H., et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012, 366:1696-1704.
6. Kodali S., Williams M., Smith C.R., et al. Two year outcomes after transcatheter or surgical replacement in high risk patients with aortic stenosis. N Engl J Med 2012, 366:1686-1695.
7. Tamburino C., Capodanno D., Ramondo A., et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011, 123:299-308.
8. Eltchaninoff H., Prat A., Gilard M., et al. Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National Corevalve and Edwards) registry. Eur Heart J 2011, 32:191-197.
9. Thomas M., Schymik G., Walther T., et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011, 124:425-433.
10. Rodés-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080-1090.
11. Moat N.E., Ludman P., de Belder M.A., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol 2011, 58:2130-2138.
12. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.
13. Reynolds M.R., Magnuson E.A., Lei Y., et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011, 124:1964-1972.
14. Reynolds M.R., Magnuson E.A., Wang K., et al. Cost effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the PARTNER trial (cohort b). Circulation 2012, 125:1102-1109.
15. Reynolds M.R., Magnuson E.A., Wang K., et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial (cohort A). J Am Coll Cardiol 2012, 60:548-558. PARTNER Trial Investigators.
16. Miller D.C., Blackstone E.H., Mack M.J., et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 2012, 143:832-843.e13.
17. Schaff H.V. Transcatheter aortic-valve implantation - at what price?. N Engl J Med 2011, 364:2256-2258.
18. Pibarot P., Dumesnil J.G. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009, 119:1034-1048.
19. Chan V., Lapierre H., Boodhwani M., et al. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation 2011, 124:S75-S80.
20. Ruel M., Chan V., Bédard P., et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults less than 60 years of age. Circulation 2007, 116:1294-1300.
21. Gurvitch R., Cheung A., Ye J., et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol 2011, 58:2196-2209.
22. Piazza N., Bleiziffer S., Brockmann G., et al. Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 1). JACC Cardiovasc Interv 2011, 4:721-732.
23. Lauck S., Achtem L., Boone R.H., et al. Implementation of processes of care to support transcatheter aortic valve replacement programs. Eur J Cardiovasc Nurs 2011, [Epub ahead of print].
24. Jayasuriya C., Moss R.R., Munt B. Transcatheter aortic valve implantation in aortic stenosis: the role of echocardiography. J Am Soc Echocardiogr 2011, 24:15-27.
25. Leipsic J., Gurvitch R., LaBounty T., et al. Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging 2011, 4:416-429.
26. Masson J.B., Kovac J., Schuler G., et al. Transcatheter aortic valve implantation: review of the nature, management and avoidance of procedural complications. JACC Cardiovasc Intervent 2009, 2:811-820.
27. Dewey T.M., Brown D.L., Herbert M.A., et al. The effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010, 89:758-767.
28. Masson J.B., Lee M., Boone R.H., et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Cathet Cardiovasc Interv 2010, 76:165-173.
29. Bagur R., Rodes-Cabau J., Dumont E., et al. Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation. Am Heart J 2011, 161:726-734.
30. Dewey T.M., Brown D., Ryan W.H., Herbert M.A., Prince S.L., Mack M.J. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008, 135:180-187.
31. Holmes D.R., Mack M.J. Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 58:445-455.
32. Ruiz C.E., Feldman T.E., Hijazi Z.M., et al. Interventional fellowship in structural and congenital heart disease for adults. Catheter Cardiovasc Interv 2010, 76:E90-E105.
33. Toggweiler S., Gurvitch R., Leipsic J., et al. Percutaneous aortic valve replacement. Improved vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012, 59:113-118.
34. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736-1754.
35. Hlatky M.A., Simons C.T. Cost-effectiveness of transcatheter aortic valve replacement. Circulation 2012, 125:1076-1077.